Cargando…

The presence of β(2)-adrenoceptors sensitizes α(2A)-adrenoceptors to desensitization after chronic epinephrine treatment

BACKGROUND: In addition to the regulation of blood pressure, α(2)- and β-adrenoceptor (AR) subtypes play an important role in the modulation of noradrenergic neurotransmission in the human CNS and PNS. Several studies suggest that the α(2)-AR responsiveness in cells and tissues after chronic epineph...

Descripción completa

Detalles Bibliográficos
Autores principales: Bawa-Khalfe, Tasneem, Altememi, Ghazi F, Mandyam, Chitra D, Schwarz, Lindsay A, Eikenburg, Douglas C, Standifer, Kelly M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2234403/
https://www.ncbi.nlm.nih.gov/pubmed/18096057
http://dx.doi.org/10.1186/1471-2210-7-16
_version_ 1782150359326654464
author Bawa-Khalfe, Tasneem
Altememi, Ghazi F
Mandyam, Chitra D
Schwarz, Lindsay A
Eikenburg, Douglas C
Standifer, Kelly M
author_facet Bawa-Khalfe, Tasneem
Altememi, Ghazi F
Mandyam, Chitra D
Schwarz, Lindsay A
Eikenburg, Douglas C
Standifer, Kelly M
author_sort Bawa-Khalfe, Tasneem
collection PubMed
description BACKGROUND: In addition to the regulation of blood pressure, α(2)- and β-adrenoceptor (AR) subtypes play an important role in the modulation of noradrenergic neurotransmission in the human CNS and PNS. Several studies suggest that the α(2)-AR responsiveness in cells and tissues after chronic epinephrine (EPI) or norepinephrine (NE) exposure may vary, depending on the β-AR activity present there. Recently, we reported that in BE(2)-C human neuroblastoma cells (endogenously expressing α(2A)- and β(2)-AR), chronic EPI treatment (300 nM) produced a dramatic β-adrenoceptor-dependent desensitization of the α(2A)-AR response. The aim of this study is to determine if stable addition of a β(2)-AR to a second neuroblastoma cell line (SH-SY5Y), that normally expresses only α(2A)-ARs that are not sensitive to 300 nM EPI exposure, would suddenly render α(2A)-ARs in that cell line sensitive to treatment with the same EPI concentration. METHODS: These studies employed RT-PCR, receptor binding and inhibition of cAMP accumulation to confirm α(2)-AR subtype expression. Stable clones of SH-SY5Y cells transfected to stably express functional β(2)-ARs (SHβ(2)AR4) were selected to compare sensitivity of α(2)-AR to EPI in the presence or absence of β(2)-ARs. RESULTS: A series of molecular, biochemical and pharmacological studies indicated that the difference between the cell lines could not be attributed to α(2)-AR heterogeneity. We now report that after transfection of functional β(2)-AR into SH-SY5Y cells (SHβ(2)AR4), chronic treatment with modest levels of EPI desensitizes the α(2A)-AR. This effect results from a β(2)-AR dependent down-regulation of native α(2A)-ARs by EPI accompanied by enhanced translocation of GRK2 and GRK3 to the membrane (required for GRK-mediated phosphorylation of agonist-occupied receptors). CONCLUSION: This study further supports the hypothesis that the presence of the β-AR renders the α(2A)-AR more susceptible to desensitization with physiological levels of EPI.
format Text
id pubmed-2234403
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22344032008-02-08 The presence of β(2)-adrenoceptors sensitizes α(2A)-adrenoceptors to desensitization after chronic epinephrine treatment Bawa-Khalfe, Tasneem Altememi, Ghazi F Mandyam, Chitra D Schwarz, Lindsay A Eikenburg, Douglas C Standifer, Kelly M BMC Pharmacol Research Article BACKGROUND: In addition to the regulation of blood pressure, α(2)- and β-adrenoceptor (AR) subtypes play an important role in the modulation of noradrenergic neurotransmission in the human CNS and PNS. Several studies suggest that the α(2)-AR responsiveness in cells and tissues after chronic epinephrine (EPI) or norepinephrine (NE) exposure may vary, depending on the β-AR activity present there. Recently, we reported that in BE(2)-C human neuroblastoma cells (endogenously expressing α(2A)- and β(2)-AR), chronic EPI treatment (300 nM) produced a dramatic β-adrenoceptor-dependent desensitization of the α(2A)-AR response. The aim of this study is to determine if stable addition of a β(2)-AR to a second neuroblastoma cell line (SH-SY5Y), that normally expresses only α(2A)-ARs that are not sensitive to 300 nM EPI exposure, would suddenly render α(2A)-ARs in that cell line sensitive to treatment with the same EPI concentration. METHODS: These studies employed RT-PCR, receptor binding and inhibition of cAMP accumulation to confirm α(2)-AR subtype expression. Stable clones of SH-SY5Y cells transfected to stably express functional β(2)-ARs (SHβ(2)AR4) were selected to compare sensitivity of α(2)-AR to EPI in the presence or absence of β(2)-ARs. RESULTS: A series of molecular, biochemical and pharmacological studies indicated that the difference between the cell lines could not be attributed to α(2)-AR heterogeneity. We now report that after transfection of functional β(2)-AR into SH-SY5Y cells (SHβ(2)AR4), chronic treatment with modest levels of EPI desensitizes the α(2A)-AR. This effect results from a β(2)-AR dependent down-regulation of native α(2A)-ARs by EPI accompanied by enhanced translocation of GRK2 and GRK3 to the membrane (required for GRK-mediated phosphorylation of agonist-occupied receptors). CONCLUSION: This study further supports the hypothesis that the presence of the β-AR renders the α(2A)-AR more susceptible to desensitization with physiological levels of EPI. BioMed Central 2007-12-20 /pmc/articles/PMC2234403/ /pubmed/18096057 http://dx.doi.org/10.1186/1471-2210-7-16 Text en Copyright © 2007 Bawa-Khalfe et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bawa-Khalfe, Tasneem
Altememi, Ghazi F
Mandyam, Chitra D
Schwarz, Lindsay A
Eikenburg, Douglas C
Standifer, Kelly M
The presence of β(2)-adrenoceptors sensitizes α(2A)-adrenoceptors to desensitization after chronic epinephrine treatment
title The presence of β(2)-adrenoceptors sensitizes α(2A)-adrenoceptors to desensitization after chronic epinephrine treatment
title_full The presence of β(2)-adrenoceptors sensitizes α(2A)-adrenoceptors to desensitization after chronic epinephrine treatment
title_fullStr The presence of β(2)-adrenoceptors sensitizes α(2A)-adrenoceptors to desensitization after chronic epinephrine treatment
title_full_unstemmed The presence of β(2)-adrenoceptors sensitizes α(2A)-adrenoceptors to desensitization after chronic epinephrine treatment
title_short The presence of β(2)-adrenoceptors sensitizes α(2A)-adrenoceptors to desensitization after chronic epinephrine treatment
title_sort presence of β(2)-adrenoceptors sensitizes α(2a)-adrenoceptors to desensitization after chronic epinephrine treatment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2234403/
https://www.ncbi.nlm.nih.gov/pubmed/18096057
http://dx.doi.org/10.1186/1471-2210-7-16
work_keys_str_mv AT bawakhalfetasneem thepresenceofb2adrenoceptorssensitizesa2aadrenoceptorstodesensitizationafterchronicepinephrinetreatment
AT altememighazif thepresenceofb2adrenoceptorssensitizesa2aadrenoceptorstodesensitizationafterchronicepinephrinetreatment
AT mandyamchitrad thepresenceofb2adrenoceptorssensitizesa2aadrenoceptorstodesensitizationafterchronicepinephrinetreatment
AT schwarzlindsaya thepresenceofb2adrenoceptorssensitizesa2aadrenoceptorstodesensitizationafterchronicepinephrinetreatment
AT eikenburgdouglasc thepresenceofb2adrenoceptorssensitizesa2aadrenoceptorstodesensitizationafterchronicepinephrinetreatment
AT standiferkellym thepresenceofb2adrenoceptorssensitizesa2aadrenoceptorstodesensitizationafterchronicepinephrinetreatment
AT bawakhalfetasneem presenceofb2adrenoceptorssensitizesa2aadrenoceptorstodesensitizationafterchronicepinephrinetreatment
AT altememighazif presenceofb2adrenoceptorssensitizesa2aadrenoceptorstodesensitizationafterchronicepinephrinetreatment
AT mandyamchitrad presenceofb2adrenoceptorssensitizesa2aadrenoceptorstodesensitizationafterchronicepinephrinetreatment
AT schwarzlindsaya presenceofb2adrenoceptorssensitizesa2aadrenoceptorstodesensitizationafterchronicepinephrinetreatment
AT eikenburgdouglasc presenceofb2adrenoceptorssensitizesa2aadrenoceptorstodesensitizationafterchronicepinephrinetreatment
AT standiferkellym presenceofb2adrenoceptorssensitizesa2aadrenoceptorstodesensitizationafterchronicepinephrinetreatment